Patent details

Basic Information

Publication number:

EP3458091

PCT Application Number:

US2017032790

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177260734

PCT Publication Number:

WO2017200969

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY WITH NOTCH AND PD-1 OR PD-L1 INHIBITORS

French Title of Invention:

TRAITEMENT D'ASSOCIATION UTILISANT DES INHIBITEURS DE NOTCH ET DE PD-1 OU PD-L1

German Title of Invention:

KOMBINATIONSTHERAPIE MIT NOTCH- UND PD-1- ODER PD-L1-HEMMERN

SPC Number:

Dates

Filing date:

16/05/2017

Grant date:

17/11/2021

EP Publication Date:

27/03/2019

PCT Publication Date:

23/11/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/11/2021

EP B1 Publication Date:

17/11/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/05/2022

Expiration date:

16/05/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/11/2021

 

 

Name:

Eli Lilly and Company

Address:

Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Inventor

1

Name:

BENDER, Mark Harrath

Address:

United States (US)

2

Name:

PATEL, Bharvin Kumar

Address:

United States (US)

3

Name:

GAO, Hong

Address:

United States (US)

Priority

Priority Number:

201662339363 P

Priority Date:

20/05/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; A61K 45/06; A61K 31/542; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202146

Publication date:

17/11/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages